Rennova Health, Inc. Announces Board of Directors WEST

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Rennova Health, Inc. Announces Board of Directors

WEST PALM BEACH, FL--(Marketwired - Nov 3, 2015) - Rennova Health, Inc. ( NASDAQ : RNVA ) announces its board of directors boasting years of experience in executive leadership, healthcare, public policy, and financial services. Following the merger between Medytox Solutions, Inc. and CollabRx, Inc. on November 2, 2015, Rennova Health, Inc.'s board includes the following seven members: Thomas R. Mika, MBA, as executive chairman of the board; Paul R. Billings, MD, PhD, FACP, FACMG , as director; Michael L. Goldberg , managing director of Monarch Capital, LLC, as director; Robert Lee , managing partner of Sheffield Investment Partners, as director; Christopher E. Diamantis , chairman and CEO of Integrated Financial Settlements, Inc.; as director; Benjamin Frank , a retired lawyer and businessman with experience in healthcare, foreign trade, retail, business development, and government, as director; and Seamus Lagan , CEO of Rennova Health, Inc., as director.

"Every board member brings with them a wealth of practical knowledge in our field, bookended by major professional accomplishments," said Seamus Lagan, CEO of Rennova Health, Inc. "I believe their expertise will become increasingly valuable as Rennova continues to expand." 

"In my experience, this is an exceptionally strong and independent board, covering all the key areas of our business," added Thomas R. Mika. "We expect to maintain a high level of integrity in our representation of all Rennova Health stakeholders."

Thomas R. Mika, MBA, Executive Chairman of the Board Thomas R. Mika, MBA, now holds the position of executive chairman of the board. Prior to his leadership role at CollabRx, Mika was appointed president and CEO of Tegal in 2005 and chairman of the board the following year. His previous service with Tegal was as executive vice president and CFO and as member of the board of directors from 1992 to 2002, during which he managed activities resulting in the company's 1995 Initial Public Offering. Mr. Mika holds an MBA from the Harvard Graduate School of Business.

Paul R. Billings, M.D., Ph.D., FACP, FACMG, Director Paul R. Billings, M.D., Ph.D., FACP, FACMG, is director of the board. He is a nationally recognized expert on genomic and precision medicine and a board-certified internist and clinical geneticist. Dr. Billings has devoted his career to improving patient care by expanding the use of medically relevant genomic technologies in clinical settings, most recently as Chief Medical Officer of Life Technologies, Inc. (acquired by Thermo Fisher Scientific, Inc. in March, 2014). Dr. Billings currently serves on the Scientific Advisory Board of the FDA, the Genomic Medicine Advisory Committee at the Dept. of Veterans Affairs, and the National Academy of Sciences Institute of Medicine's Roundtable on Genomics. He holds an M.D. from Harvard Medical School and a Ph.D. in immunology from Harvard University.

Christopher E. Diamantis, Director Christopher E. Diamantis has served since 1999 as chairman and CEO of Integrated Financial Settlements, Inc., a structured settlement consulting firm in Tallahassee, Florida. He also has been, since April 2000, director and managing partner of the Gabor Agency, Inc., a 63-year old Florida-based company specializing in investment and insurance planning for public employees and universities. Since 2007, Mr. Diamantis has been chairman of Pro Bank Financial Holding Company, the parent of Pro Bank, a community bank in Tallahassee, Florida. He also has served as director of Esquire Bank, a full-service, federally chartered savings bank in New York City, since 2011.

Benjamin Frank, Director Benjamin Frank is a retired lawyer and businessman, with particular experience in healthcare, foreign trade, retail, business development, and government. He served from 1971 to 1987 as vice president and trustee of North Shore University Hospital, currently North Shore University Hospital, Long Island Jewish Hospital System. Mr. Frank was appointed in February 2009 by former Florida governor Charlie Crist to the board of the Health Care District of Palm Beach County, and he served as chair of the board from October 2011 to February 2013.

Michael L. Goldberg, Director Michael L. Goldberg is the managing director of Monarch Capital, LLC, a corporate consulting company primarily servicing small to mid-sized public and private companies. Prior to his position at Monarch, he served as acting president and CEO of IDO Security, Inc., from 2006 to 2013. He has also served as a consultant to a number of private and public companies to assist in formation and capital structure. Mr. Goldberg began his career as an Asper Fellow in the U.S. Attorney's office in 1974 with the Criminal Division of the Department of Justice in Washington, D.C. (Watergate prosecution team) before becoming an assistant district attorney. He has served as a director of both private and publicly traded companies and has served on audit and compensation committees.

Seamus Lagan, Director Seamus Lagan brings over 20 years' experience in the restructure, development, and management of startup and small companies in both the private and public sector. Mr. Lagan was the CEO of the two main subsidiaries of Medytox since 2011, whereupon he was appointed CEO of Medytox Solutions, Inc. in October 2014, and has been a key factor in both the merger of the two companies and the development of Rennova's business plan.

Robert Lee, Director Robert Lee is the managing partner of Sheffield Investment Partners, a position he has held since 2010. From 2008 to 2010, Mr. Lee served as managing director of New Stream Capital, and from 2000 to 2007, he was managing director at CRT Capital Group. Mr. Lee is a board member of SL Investment Management. From 2001 to 2008, Mr. Lee served on the board of Springs Industries, and from 2008 until 2013, Mr. Lee served on the board of Springs Window Fashions. Mr. Lee is a former chairman of the Wake Forest School of Business, where he currently serves on the board of visitors.

About Rennova Health, Inc. Rennova Health provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcome. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare.

Safe Harbor Statement This press release contains certain forward-looking information about Rennova Health, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Words such as "guidance", "expect", "will", "may", "anticipate", "plan", "estimate", "project", "intend", "should", "can", "likely", "could", and similar expressions are intended to identify forward looking statements. These statements include statements about our plans, strategies and prospects. Forward-looking statements are not guarantees of performance. These statements are based upon the current beliefs and expectations of our management and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot assure you that the expectations will prove to be correct. Important factors that could cause our actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov . You should not place undue reliance on these forward-looking statements, which speak only as of the date such statements are made. Except to the extent required by applicable law or regulation, we undertake no obligation to update or publish revised forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.

Media Contact: Meieli Sawyer (305) 668-0070 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 121

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 173

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 210

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 126

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 123

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 175

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 95

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 203

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading

Top 5 Most Recently Viewed Articles

dbt Labs Transforms Data Management with MetricFlow Open Source

Updated Category News Views 735

Embracing Open Source with MetricFlow In a groundbreaking move, dbt Labs recently announced its commitment to advancing trustworthy AI by open sourcing MetricFlow. This initiative represents a significant turning point in how organizations manage and utilize data in the era of artificial intelligence. The shift to an Apache 2.0 license not only safeguards the integrity of...

Continue Reading
EssilorLuxottica Achieves Euro 2 Billion Bond Issuance Success

Updated Category News Views 117

EssilorLuxottica's Successful Bond Issuance EssilorLuxottica has reached a noteworthy milestone by successfully issuing a Euro 2 billion bond at an attractive average rate of 2.99%. This strategic financial move highlights the company's strong position in the market and its appeal to investors. Details of the Bond Issuance The bond issuance features tenors of 4.5 years...

Continue Reading
Streamlined Home Selling Solutions Introduced in North Carolina

Updated Category News Views 292

Revolutionizing Home Selling in North Carolina Fair Cash Offers For Homes has recently launched its innovative service, ‘Sell Your House Fast North Carolina,’ designed to facilitate quick and efficient sales for homeowners. With the ever-changing real estate landscape, many individuals find themselves needing to sell their properties under various circumstances,...

Continue Reading
Ipsen Employee Admits to Insider Trading on Cancer Drug Deal

Updated Category News Views 268

Guilty Plea Tied to a Drugmaker’s Takeover Plans An employee at the French pharmaceutical company Ipsen has agreed to plead guilty to insider trading. The case, centered on trading ahead of a proposed acquisition, underscores the stakes around confidentiality in drug development and the pressures that test corporate governance. What Prosecutors Allege Dishant Gupta,...

Continue Reading
Oscar Health Achieves 52-Week Record with $23.45 Stock Price

Updated Category News Views 221

Oscar Health Achieves New Stock Performance Highs In a striking example of market resilience, Oscar Health, Inc. (OSCR) has reached an impressive 52-week high with its stock hitting $23.45. This achievement signifies a remarkable growth phase for the company, which has experienced an incredible one-year change of 288.51%. Investors have shown strong support for Oscar...

Continue Reading